Literature DB >> 14747357

Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation.

Howard E Davis1, Matthew Rosinski, Jeffrey R Morgan, Martin L Yarmush.   

Abstract

The specific mechanisms of charged polymer modulation of retrovirus transduction were analyzed by characterizing their effects on virus transport and adsorption. From a standard colloidal perspective two mechanisms, charge shielding and virus aggregation, can potentially account for the experimentally observed changes in adsorption behavior and biophysical parameters due to charged polymers. Experimental testing revealed that both mechanisms could be at work depending on the characteristics of the cationic polymer. All cationic polymers enhanced adsorption and transduction via charge shielding; however, only polymers greater than 15 kDa in size were capable of enhancing these processes via the virus aggregation mechanism, explaining the higher efficiency enhancement of the high molecular weight molecules. The role of anionic polymers was also characterized and they were found to inhibit transduction via sequestration of cationic polymers, thereby preventing charge shielding and virus aggregation. Taken together, these findings suggest the basis for a revised physical model of virus transport that incorporates electrostatic interactions through both virus-cell repulsive and attractive interactions, as well as the aggregation state of the virus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747357      PMCID: PMC1303915          DOI: 10.1016/S0006-3495(04)74197-1

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  21 in total

1.  Kinetics of retrovirus production and decay.

Authors:  J M Le Doux; H E Davis; J R Morgan; M L Yarmush
Journal:  Biotechnol Bioeng       Date:  1999-06-20       Impact factor: 4.530

Review 2.  Intermolecular forces in biology.

Authors:  D Leckband; J Israelachvili
Journal:  Q Rev Biophys       Date:  2001-05       Impact factor: 5.318

Review 3.  Nucleic acid biotechnology.

Authors:  C M Roth; M L Yarmush
Journal:  Annu Rev Biomed Eng       Date:  1999       Impact factor: 9.590

4.  Physics of chemoreception.

Authors:  H C Berg; E M Purcell
Journal:  Biophys J       Date:  1977-11       Impact factor: 4.033

5.  Differential inhibition of retrovirus transduction by proteoglycans and free glycosaminoglycans.

Authors:  J M Le Doux; J R Morgan; M L Yarmush
Journal:  Biotechnol Prog       Date:  1999 May-Jun

Review 6.  Penetration of viral genetic material into host cell.

Authors:  A G Bukrinskaya
Journal:  Adv Virus Res       Date:  1982       Impact factor: 9.937

7.  Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.

Authors:  M Cavazzana-Calvo; S Hacein-Bey; G de Saint Basile; F Gross; E Yvon; P Nusbaum; F Selz; C Hue; S Certain; J L Casanova; P Bousso; F L Deist; A Fischer
Journal:  Science       Date:  2000-04-28       Impact factor: 47.728

8.  High efficiencies of gene transfer with immobilized recombinant retrovirus: kinetics and optimization.

Authors:  B Bajaj; P Lei; S T Andreadis
Journal:  Biotechnol Prog       Date:  2001 Jul-Aug

9.  Polybrene increases retrovirus gene transfer efficiency by enhancing receptor-independent virus adsorption on target cell membranes.

Authors:  Howard E Davis; Jeffrey R Morgan; Martin L Yarmush
Journal:  Biophys Chem       Date:  2002-06-19       Impact factor: 2.352

10.  Toward a more accurate quantitation of the activity of recombinant retroviruses: alternatives to titer and multiplicity of infection.

Authors:  S Andreadis; T Lavery; H E Davis; J M Le Doux; M L Yarmush; J R Morgan
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

View more
  58 in total

Review 1.  Imaging intracellular protein dynamics by spinning disk confocal microscopy.

Authors:  Samantha Stehbens; Hayley Pemble; Lyndsay Murrow; Torsten Wittmann
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

2.  Self-assembly and optically triggered disassembly of hierarchical dendron-virus complexes.

Authors:  Mauri A Kostiainen; Oksana Kasyutich; Jeroen J L M Cornelissen; Roeland J M Nolte
Journal:  Nat Chem       Date:  2010-03-21       Impact factor: 24.427

3.  Entry kinetics and cell-cell transmission of surface-bound retroviral vector particles.

Authors:  Lee S O'Neill; Amy M Skinner; Josha A Woodward; Peter Kurre
Journal:  J Gene Med       Date:  2010-05       Impact factor: 4.565

4.  Enhancement of enveloped virus entry by phosphatidylserine.

Authors:  David A Coil; A Dusty Miller
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Time frames for neutralization during the human immunodeficiency virus type 1 entry phase, as monitored in synchronously infected cell cultures.

Authors:  Hillel Haim; Israel Steiner; Amos Panet
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

6.  Rapid dissociation of HIV-1 from cultured cells severely limits infectivity assays, causes the inactivation ascribed to entry inhibitors, and masks the inherently high level of infectivity of virions.

Authors:  Emily J Platt; Susan L Kozak; James P Durnin; Thomas J Hope; David Kabat
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

7.  Directional spread of surface-associated retroviruses regulated by differential virus-cell interactions.

Authors:  Nathan M Sherer; Jing Jin; Walther Mothes
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

8.  Nucleic acid-binding polymers as anti-inflammatory agents.

Authors:  Jaewoo Lee; Jang Wook Sohn; Ying Zhang; Kam W Leong; David Pisetsky; Bruce A Sullenger
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

9.  Helical conformation of the SEVI precursor peptide PAP248-286, a dramatic enhancer of HIV infectivity, promotes lipid aggregation and fusion.

Authors:  Jeffrey R Brender; Kevin Hartman; Lindsey M Gottler; Marchello E Cavitt; Daniel W Youngstrom; Ayyalusamy Ramamoorthy
Journal:  Biophys J       Date:  2009-11-04       Impact factor: 4.033

Review 10.  Gene Therapy for Beta-Hemoglobinopathies: Milestones, New Therapies and Challenges.

Authors:  Valentina Ghiaccio; Maxwell Chappell; Stefano Rivella; Laura Breda
Journal:  Mol Diagn Ther       Date:  2019-04       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.